Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
RH price target raised to $450 from $380 at UBS » 08:07
11/24/20
11/24
08:07
11/24/20
08:07
RH

RH

$440.80 /

+1.68 (+0.38%)

, WSM

Williams-Sonoma

$112.89 /

+5.13 (+4.76%)

, ETH

Ethan Allen

$18.13 /

+0.15 (+0.83%)

, HVT

Havertys

$28.79 /

+0.99 (+3.56%)

UBS analyst Michael…

UBS analyst Michael Lasser raised the firm's price target on RH (RH) to $450 from $380 but keeps a Neutral rating on the shares ahead of its Q3 results. The analyst says that demand for Home Furnishing was very strong in the quarter as evidenced by results from Williams-Sonoma (WSM), Ethan Alllen (ETH), and Havertys (HVT). Lasser adds that he also sees RH as being "over-indexed" to products related to working from home.

ShowHide Related Items >><<
WSM Williams-Sonoma
$112.89 /

+5.13 (+4.76%)

RH RH
$440.80 /

+1.68 (+0.38%)

HVT Havertys
$28.79 /

+0.99 (+3.56%)

ETH Ethan Allen
$18.13 /

+0.15 (+0.83%)

RH RH
$440.80 /

+1.68 (+0.38%)

11/12/20 JPMorgan
RH price target raised to $530 from $440 at JPMorgan
10/19/20 Jefferies
RH initiated with an Underperform at Jefferies
10/07/20 Barclays
RH price target raised to $473 from $446 at Barclays
09/29/20
Fly Intel: Top five analyst upgrades
WSM Williams-Sonoma
$112.89 /

+5.13 (+4.76%)

11/20/20 RBC Capital
Williams-Sonoma price target raised to $117 from $101 at RBC Capital
11/20/20 Loop Capital
Williams-Sonoma price target raised to $110 from $100 at Loop Capital
11/20/20 Wedbush
Williams-Sonoma price target raised to $130 from $115 at Wedbush
11/20/20 Barclays
Williams-Sonoma price target raised to $144 from $112 at Barclays
ETH Ethan Allen
$18.13 /

+0.15 (+0.83%)

HVT Havertys
$28.79 /

+0.99 (+3.56%)

10/07/20 Sidoti
Havertys upgraded to Buy from Neutral at Sidoti
WSM Williams-Sonoma
$112.89 /

+5.13 (+4.76%)

RH RH
$440.80 /

+1.68 (+0.38%)

HVT Havertys
$28.79 /

+0.99 (+3.56%)

ETH Ethan Allen
$18.13 /

+0.15 (+0.83%)

WSM Williams-Sonoma
$112.89 /

+5.13 (+4.76%)

RH RH
$440.80 /

+1.68 (+0.38%)

WSM Williams-Sonoma
$112.89 /

+5.13 (+4.76%)

RH RH
$440.80 /

+1.68 (+0.38%)

ETH Ethan Allen
$18.13 /

+0.15 (+0.83%)

WSM Williams-Sonoma
$112.89 /

+5.13 (+4.76%)

RH RH
$440.80 /

+1.68 (+0.38%)

Recommendations
RH price target raised to $530 from $440 at JPMorgan » 08:31
11/12/20
11/12
08:31
11/12/20
08:31
RH

RH

$409.60 /

+30.39 (+8.01%)

JPMorgan analyst Tami…

JPMorgan analyst Tami Zakaria raised the firm's price target on RH to $530 from $440 and reiterates an Overweight rating on the shares. The company is "primed for a luxury growth stock re-rating" in 2021 based on sales acceleration and an impending entry to England, Zakaria tells investors in a research note. Further, the analyst believes RH's operating margin should continue to rise from the 20% "high-water mark." She expects the company to benefit from pent-up demand and footage growth acceleration in 2021 and 2022.

ShowHide Related Items >><<
RH RH
$409.60 /

+30.39 (+8.01%)

RH RH
$409.60 /

+30.39 (+8.01%)

10/19/20 Jefferies
RH initiated with an Underperform at Jefferies
10/07/20 Barclays
RH price target raised to $473 from $446 at Barclays
09/29/20
Fly Intel: Top five analyst upgrades
09/29/20 Cowen
Cowen upgrades RH to Outperform with transformation in 'earlier innings'
RH RH
$409.60 /

+30.39 (+8.01%)

RH RH
$409.60 /

+30.39 (+8.01%)

RH RH
$409.60 /

+30.39 (+8.01%)

RH RH
$409.60 /

+30.39 (+8.01%)

Over a month ago
Conference/Events
Cowen consumer goods/luxury analyst to hold analyst/industry conference call » 10:25
10/28/20
10/28
10:25
10/28/20
10:25
RH

RH

$357.77 /

-6.33 (-1.74%)

Consumer Goods/Luxury…

Consumer Goods/Luxury Analyst Rakhlenko discusses the state of the Luxury Furniture Industry and outlook for 2021 on an Analyst/Industry conference call to be held on October 28 at 11 am.

ShowHide Related Items >><<
RH RH
$357.77 /

-6.33 (-1.74%)

RH RH
$357.77 /

-6.33 (-1.74%)

10/19/20 Jefferies
RH initiated with an Underperform at Jefferies
10/07/20 Barclays
RH price target raised to $473 from $446 at Barclays
09/29/20
Fly Intel: Top five analyst upgrades
09/29/20 Cowen
Cowen upgrades RH to Outperform with transformation in 'earlier innings'
RH RH
$357.77 /

-6.33 (-1.74%)

RH RH
$357.77 /

-6.33 (-1.74%)

RH RH
$357.77 /

-6.33 (-1.74%)

RH RH
$357.77 /

-6.33 (-1.74%)

Conference/Events
Cowen consumer goods/luxury analyst to hold analyst/industry conference call » 04:55
10/28/20
10/28
04:55
10/28/20
04:55
RH

RH

$364.00 /

-1.095 (-0.30%)

Consumer Goods/Luxury…

Consumer Goods/Luxury Analyst Rakhlenko discusses the state of the Luxury Furniture Industry and outlook for 2021 on an Analyst/Industry conference call to be held on October 28 at 11 am.

ShowHide Related Items >><<
RH RH
$364.00 /

-1.095 (-0.30%)

RH RH
$364.00 /

-1.095 (-0.30%)

10/19/20 Jefferies
RH initiated with an Underperform at Jefferies
10/07/20 Barclays
RH price target raised to $473 from $446 at Barclays
09/29/20
Fly Intel: Top five analyst upgrades
09/29/20 Cowen
Cowen upgrades RH to Outperform with transformation in 'earlier innings'
RH RH
$364.00 /

-1.095 (-0.30%)

RH RH
$364.00 /

-1.095 (-0.30%)

RH RH
$364.00 /

-1.095 (-0.30%)

RH RH
$364.00 /

-1.095 (-0.30%)

Conference/Events
Cowen consumer goods/luxury analyst to hold analyst/industry conference call » 14:24
10/27/20
10/27
14:24
10/27/20
14:24
RH

RH

$366.38 /

+1.285 (+0.35%)

Consumer Goods/Luxury…

Consumer Goods/Luxury Analyst Rakhlenko discusses the state of the Luxury Furniture Industry and outlook for 2021 on an Analyst/Industry conference call to be held on October 28 at 11 am.

ShowHide Related Items >><<
RH RH
$366.38 /

+1.285 (+0.35%)

RH RH
$366.38 /

+1.285 (+0.35%)

10/19/20 Jefferies
RH initiated with an Underperform at Jefferies
10/07/20 Barclays
RH price target raised to $473 from $446 at Barclays
09/29/20
Fly Intel: Top five analyst upgrades
09/29/20 Cowen
Cowen upgrades RH to Outperform with transformation in 'earlier innings'
RH RH
$366.38 /

+1.285 (+0.35%)

RH RH
$366.38 /

+1.285 (+0.35%)

RH RH
$366.38 /

+1.285 (+0.35%)

RH RH
$366.38 /

+1.285 (+0.35%)

On The Fly
UnitedHealth downgrade, Tesla target raise among top calls on Wall Street » 09:59
10/19/20
10/19
09:59
10/19/20
09:59
UNH

UnitedHealth

$329.87 /

-0.05 (-0.02%)

, TSLA

Tesla

$444.43 /

+4.52 (+1.03%)

, VFC

VF Corp.

$75.10 /

-0.74 (-0.98%)

, NKE

Nike

$129.39 /

+1.38 (+1.08%)

, MDRX

Allscripts

$11.00 /

-0.075 (-0.68%)

, RH

RH

$377.51 /

-7.49 (-1.95%)

Check out today's top…

ShowHide Related Items >><<
VFC VF Corp.
$75.10 /

-0.74 (-0.98%)

UNH UnitedHealth
$329.87 /

-0.05 (-0.02%)

TSLA Tesla
$444.43 /

+4.52 (+1.03%)

RH RH
$377.51 /

-7.49 (-1.95%)

NKE Nike
$129.39 /

+1.38 (+1.08%)

MDRX Allscripts
$11.00 /

-0.075 (-0.68%)

UNH UnitedHealth
$329.87 /

-0.05 (-0.02%)

10/19/20
Fly Intel: Top five analyst downgrades
10/19/20 Argus
UnitedHealth downgraded to Hold from Buy at Argus
10/19/20 Argus
UnitedHealth downgraded to Hold from Buy at Argus
10/15/20 RBC Capital
UnitedHealth price target raised to $389 from $384 at RBC Capital
TSLA Tesla
$444.43 /

+4.52 (+1.03%)

10/19/20 Wedbush
Tesla price target raised to $500 from $475 at Wedbush
10/16/20 Morgan Stanley
Tesla price target raised to $333 from $272 at Morgan Stanley
10/14/20 Credit Suisse
Q3 beat could be positive catalyst for Tesla stock, says Credit Suisse
10/14/20 JPMorgan
NIO Inc. upgraded to Overweight from Neutral at JPMorgan
VFC VF Corp.
$75.10 /

-0.74 (-0.98%)

10/19/20 RBC Capital
VF Corp. price target raised to $84 from $66 at RBC Capital
10/19/20 BofA
VF Corp. downgraded to Underperform from Neutral at BofA
10/19/20 BofA
VF Corp. downgraded to Underperform from Neutral at BofA
10/15/20 Cowen
VF Corp. price target raised to $81 from $64 at Cowen
NKE Nike
$129.39 /

+1.38 (+1.08%)

10/15/20 Piper Sandler
Nike price target raised to $153 from $148 at Piper Sandler
10/13/20 BofA
BofA double upgrades Foot Locker to Buy on Nike product momentum
10/06/20 Piper Sandler
Piper teen survey shows Snap, Amazon and Apple remain favorites
MDRX Allscripts
$11.00 /

-0.075 (-0.68%)

10/19/20 Baird
Baird calls Allscripts "classic value trap", downgrades to Neutral
10/19/20 Baird
Allscripts downgraded to Neutral from Outperform at Baird
10/14/20 Piper Sandler
Allscripts selling everything investors want to own, says Piper Sandler
07/21/20 Goldman Sachs
Allscripts downgraded to Sell from Neutral at Goldman Sachs
RH RH
$377.51 /

-7.49 (-1.95%)

10/19/20 Jefferies
RH initiated with an Underperform at Jefferies
10/07/20 Barclays
RH price target raised to $473 from $446 at Barclays
09/29/20
Fly Intel: Top five analyst upgrades
09/29/20 Cowen
Cowen upgrades RH to Outperform with transformation in 'earlier innings'
VFC VF Corp.
$75.10 /

-0.74 (-0.98%)

UNH UnitedHealth
$329.87 /

-0.05 (-0.02%)

TSLA Tesla
$444.43 /

+4.52 (+1.03%)

RH RH
$377.51 /

-7.49 (-1.95%)

NKE Nike
$129.39 /

+1.38 (+1.08%)

MDRX Allscripts
$11.00 /

-0.075 (-0.68%)

  • 14
    Feb
VFC VF Corp.
$75.10 /

-0.74 (-0.98%)

UNH UnitedHealth
$329.87 /

-0.05 (-0.02%)

TSLA Tesla
$444.43 /

+4.52 (+1.03%)

RH RH
$377.51 /

-7.49 (-1.95%)

NKE Nike
$129.39 /

+1.38 (+1.08%)

VFC VF Corp.
$75.10 /

-0.74 (-0.98%)

UNH UnitedHealth
$329.87 /

-0.05 (-0.02%)

TSLA Tesla
$444.43 /

+4.52 (+1.03%)

RH RH
$377.51 /

-7.49 (-1.95%)

NKE Nike
$129.39 /

+1.38 (+1.08%)

MDRX Allscripts
$11.00 /

-0.075 (-0.68%)

VFC VF Corp.
$75.10 /

-0.74 (-0.98%)

UNH UnitedHealth
$329.87 /

-0.05 (-0.02%)

TSLA Tesla
$444.43 /

+4.52 (+1.03%)

RH RH
$377.51 /

-7.49 (-1.95%)

NKE Nike
$129.39 /

+1.38 (+1.08%)

Initiation
RH initiated with an Underperform at Jefferies » 08:08
10/19/20
10/19
08:08
10/19/20
08:08
RH

RH

$385.31 /

-4.25 (-1.09%)

Jefferies analyst…

Jefferies analyst Jonathan Matuszewski initiated coverage of RH with an Underperform rating and $320 price target. While RH has opened 24 "architecturally inspiring locations" with impressive lifts to physical and digital sales over the last decade, Matuszewski said he has trouble believing the next two dozen galleries will see returns consistent with those "initial, cherry-picked projects." The retailer is almost entirely domestic and while he doesn't doubt there is potential abroad, Matuszewski believes Street estimates may not be focusing on potential deleverage from investments and ad spending for brand awareness that "could mount quickly," he added.

ShowHide Related Items >><<
RH RH
$385.31 /

-4.25 (-1.09%)

RH RH
$385.31 /

-4.25 (-1.09%)

10/07/20 Barclays
RH price target raised to $473 from $446 at Barclays
09/29/20
Fly Intel: Top five analyst upgrades
09/29/20 Cowen
Cowen upgrades RH to Outperform with transformation in 'earlier innings'
09/29/20 Cowen
RH upgraded to Outperform from Market Perform at Cowen
RH RH
$385.31 /

-4.25 (-1.09%)

RH RH
$385.31 /

-4.25 (-1.09%)

RH RH
$385.31 /

-4.25 (-1.09%)

RH RH
$385.31 /

-4.25 (-1.09%)

Recommendations
RH price target raised to $473 from $446 at Barclays » 06:19
10/07/20
10/07
06:19
10/07/20
06:19
RH

RH

$362.02 /

-17.915 (-4.72%)

Barclays analyst Adrienne…

Barclays analyst Adrienne Yih raised the firm's price target on RH to $473 from $446 and keeps an Overweight rating on the shares. In the wake of COVID, the Retail segment is reducing supply on multiple levels and forcing store closures as e-commerce growth accelerates, Yih tells investors in a research note.

ShowHide Related Items >><<
RH RH
$362.02 /

-17.915 (-4.72%)

RH RH
$362.02 /

-17.915 (-4.72%)

09/29/20
Fly Intel: Top five analyst upgrades
09/29/20 Cowen
Cowen upgrades RH to Outperform with transformation in 'earlier innings'
09/29/20 Cowen
RH upgraded to Outperform from Market Perform at Cowen
09/10/20 JPMorgan
RH price target raised to $440 from $370 at JPMorgan
RH RH
$362.02 /

-17.915 (-4.72%)

RH RH
$362.02 /

-17.915 (-4.72%)

RH RH
$362.02 /

-17.915 (-4.72%)

RH RH
$362.02 /

-17.915 (-4.72%)

On The Fly
Hersey, Best Buy upgrades among today's top calls on Wall Street » 10:00
09/29/20
09/29
10:00
09/29/20
10:00
HSY

Hershey

$141.40 /

+1.06 (+0.76%)

, BBY

Best Buy

$109.07 /

+0.69 (+0.64%)

, EL

Estee Lauder

$215.07 /

-0.42 (-0.19%)

, RH

RH

$371.30 /

+10.64 (+2.95%)

, BMY

Bristol-Myers

$60.19 /

+0.465 (+0.78%)

, AZN

AstraZeneca

$55.04 /

+0.33 (+0.60%)

, PFE

Pfizer

$36.38 /

-0.03 (-0.08%)

, MRK

Merck

$82.78 /

-0.02 (-0.02%)

, LLY

Eli Lilly

$148.31 /

+0.4 (+0.27%)

, ABBV

AbbVie

$86.86 /

-0.37 (-0.42%)

, NVS

Novartis

$87.81 /

+0.785 (+0.90%)

, SNY

Sanofi

$50.90 /

-0.05 (-0.10%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Check out today's top…

ShowHide Related Items >><<
SNY Sanofi
$50.90 /

-0.05 (-0.10%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RH RH
$371.30 /

+10.64 (+2.95%)

PFE Pfizer
$36.38 /

-0.03 (-0.08%)

NVS Novartis
$87.81 /

+0.785 (+0.90%)

MRK Merck
$82.78 /

-0.02 (-0.02%)

LLY Eli Lilly
$148.31 /

+0.4 (+0.27%)

HSY Hershey
$141.40 /

+1.06 (+0.76%)

EL Estee Lauder
$215.07 /

-0.42 (-0.19%)

BMY Bristol-Myers
$60.19 /

+0.465 (+0.78%)

BBY Best Buy
$109.07 /

+0.69 (+0.64%)

AZN AstraZeneca
$55.04 /

+0.33 (+0.60%)

ABBV AbbVie
$86.86 /

-0.37 (-0.42%)

HSY Hershey
$141.40 /

+1.06 (+0.76%)

09/29/20
Fly Intel: Top five analyst upgrades
09/29/20 BMO Capital
Hershey upgraded to Outperform from Market Perform at BMO Capital
07/24/20 Evercore ISI
Hershey upgraded to Outperform from In Line at Evercore ISI
04/24/20
Fly Intel: Top five analyst downgrades
BBY Best Buy
$109.07 /

+0.69 (+0.64%)

09/29/20 Cleveland Research
Best Buy upgraded to Buy from Neutral at Cleveland Research
09/29/20 Cleveland Research
Best Buy upgraded to Buy from Neutral at Cleveland Research
09/01/20 Loop Capital
Best Buy pricing narrows relative to Amazon.com, says Loop Capital
08/27/20 DA Davidson
Dick's Sporting price target raised to $67 from $57 at DA Davidson
EL Estee Lauder
$215.07 /

-0.42 (-0.19%)

09/28/20 Goldman Sachs
Estee Lauder upgraded to Neutral from Sell at Goldman Sachs
09/04/20 Raymond James
Estee Lauder price target raised to $235 from $210 at Raymond James
09/03/20 Morgan Stanley
Brown-Forman price target raised to $66 from $56 at Morgan Stanley
08/26/20 Argus
Estee Lauder price target raised to $240 from $220 at Argus
RH RH
$371.30 /

+10.64 (+2.95%)

09/29/20 Cowen
Cowen upgrades RH to Outperform with transformation in 'earlier innings'
09/29/20 Cowen
RH upgraded to Outperform from Market Perform at Cowen
09/10/20 JPMorgan
RH price target raised to $440 from $370 at JPMorgan
BMY Bristol-Myers
$60.19 /

+0.465 (+0.78%)

09/29/20 Berenberg
Bristol-Myers initiated with a Buy at Berenberg
09/22/20 Oppenheimer
Bluebird Bio review timeline consistent with expectations, says Oppenheimer
08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
AZN AstraZeneca
$55.04 /

+0.33 (+0.60%)

09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
09/23/20 Oddo BHF
AstraZeneca upgraded to Buy from Reduce at Oddo BHF
09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
PFE Pfizer
$36.38 /

-0.03 (-0.08%)

09/29/20
Fly Intel: Top five analyst initiations
09/29/20 Berenberg
Pfizer initiated with a Hold at Berenberg
09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Baird
uniQure weakness a buying opportunity, says Baird
MRK Merck
$82.78 /

-0.02 (-0.02%)

09/29/20 Berenberg
Merck initiated with a Hold at Berenberg
09/24/20 Roth Capital
Merck data suggests 'another shot on goal' for Jounce, says Roth Capital
09/22/20 Stifel
Seattle Genetics price target raised to $165 from $145 at Stifel
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
LLY Eli Lilly
$148.31 /

+0.4 (+0.27%)

09/29/20 Berenberg
Eli Lilly initiated with a Hold at Berenberg
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
ABBV AbbVie
$86.86 /

-0.37 (-0.42%)

09/29/20 Berenberg
AbbVie initiated with a Hold at Berenberg
09/28/20 Mizuho
Mizuho 'incrementally more bullish' on AbbVie integration of Allergan
09/02/20 Citi
AbbVie revenue potential offsets subpoena risk, says Citi
08/24/20 H.C. Wainwright
Galapagos downgraded to Neutral from Buy at H.C. Wainwright
NVS Novartis
$87.81 /

+0.785 (+0.90%)

09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
SNY Sanofi
$50.90 /

-0.05 (-0.10%)

09/29/20 Berenberg
Sanofi initiated with a Hold at Berenberg
09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
RHHBY Roche
$0.00 /

+ (+0.00%)

09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
09/28/20 Societe Generale
Roche price target raised to CHF 420 from CHF 365 at Societe Generale
09/23/20 BMO Capital
Blueprint Medicines price target raised to $113 from $105 at BMO Capital
SNY Sanofi
$50.90 /

-0.05 (-0.10%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RH RH
$371.30 /

+10.64 (+2.95%)

PFE Pfizer
$36.38 /

-0.03 (-0.08%)

NVS Novartis
$87.81 /

+0.785 (+0.90%)

MRK Merck
$82.78 /

-0.02 (-0.02%)

LLY Eli Lilly
$148.31 /

+0.4 (+0.27%)

HSY Hershey
$141.40 /

+1.06 (+0.76%)

EL Estee Lauder
$215.07 /

-0.42 (-0.19%)

BMY Bristol-Myers
$60.19 /

+0.465 (+0.78%)

BBY Best Buy
$109.07 /

+0.69 (+0.64%)

AZN AstraZeneca
$55.04 /

+0.33 (+0.60%)

ABBV AbbVie
$86.86 /

-0.37 (-0.42%)

SNY Sanofi
$50.90 /

-0.05 (-0.10%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RH RH
$371.30 /

+10.64 (+2.95%)

PFE Pfizer
$36.38 /

-0.03 (-0.08%)

NVS Novartis
$87.81 /

+0.785 (+0.90%)

MRK Merck
$82.78 /

-0.02 (-0.02%)

LLY Eli Lilly
$148.31 /

+0.4 (+0.27%)

HSY Hershey
$141.40 /

+1.06 (+0.76%)

EL Estee Lauder
$215.07 /

-0.42 (-0.19%)

BMY Bristol-Myers
$60.19 /

+0.465 (+0.78%)

BBY Best Buy
$109.07 /

+0.69 (+0.64%)

AZN AstraZeneca
$55.04 /

+0.33 (+0.60%)

SNY Sanofi
$50.90 /

-0.05 (-0.10%)

RH RH
$371.30 /

+10.64 (+2.95%)

PFE Pfizer
$36.38 /

-0.03 (-0.08%)

NVS Novartis
$87.81 /

+0.785 (+0.90%)

MRK Merck
$82.78 /

-0.02 (-0.02%)

LLY Eli Lilly
$148.31 /

+0.4 (+0.27%)

HSY Hershey
$141.40 /

+1.06 (+0.76%)

EL Estee Lauder
$215.07 /

-0.42 (-0.19%)

BMY Bristol-Myers
$60.19 /

+0.465 (+0.78%)

BBY Best Buy
$109.07 /

+0.69 (+0.64%)

AZN AstraZeneca
$55.04 /

+0.33 (+0.60%)

ABBV AbbVie
$86.86 /

-0.37 (-0.42%)

SNY Sanofi
$50.90 /

-0.05 (-0.10%)

RH RH
$371.30 /

+10.64 (+2.95%)

PFE Pfizer
$36.38 /

-0.03 (-0.08%)

MRK Merck
$82.78 /

-0.02 (-0.02%)

LLY Eli Lilly
$148.31 /

+0.4 (+0.27%)

EL Estee Lauder
$215.07 /

-0.42 (-0.19%)

BMY Bristol-Myers
$60.19 /

+0.465 (+0.78%)

BBY Best Buy
$109.07 /

+0.69 (+0.64%)

AZN AstraZeneca
$55.04 /

+0.33 (+0.60%)

ABBV AbbVie
$86.86 /

-0.37 (-0.42%)

Upgrade
Fly Intel: Top five analyst upgrades » 09:54
09/29/20
09/29
09:54
09/29/20
09:54
D

Dominion

$78.70 /

+1.56 (+2.02%)

, HSY

Hershey

$141.71 /

+1.37 (+0.98%)

, SQ

Square

$165.06 /

+4.3 (+2.67%)

, RH

RH

$372.50 /

+11.84 (+3.28%)

, FWRD

Forward Air

$58.50 /

+2.09 (+3.71%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Dominion (D) upgraded to Overweight from Neutral at JPMorgan with analyst Jeremy Tonet saying U.S. utilities are "ideally situated" to capitalize on state environmental policies that continue to increase and accelerate renewable energy initiatives. 2. Hershey (HSY) upgraded to Outperform from Market Perform at BMO Capital with analyst Kenneth Zaslow saying despite an ongoing valuation premium to its food peers, Hershey has become a "compelling investment." 3. Square (SQ) upgraded to Outperform from Peer Perform at Wolfe Research. 4. RH (RH) upgraded to Outperform from Market Perform at Cowen with analyst Max Rakhlenko saying he is constructive on RH's transformation and sees upside to the company's long-term targets on revenue. 5. Forward Air (FWRD) upgraded to Outperform from Market Perform at Raymond James with analyst Patrick Tyler Brown saying he views Forward as uniquely positioned to capitalize on a tightening freight market and a robust LTL pricing backdrop, anchored by its accelerating LTL door-door expansion, primarily focused on time sensitive LTL freight. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SQ Square
$165.06 /

+4.3 (+2.67%)

RH RH
$372.50 /

+11.84 (+3.28%)

HSY Hershey
$141.71 /

+1.37 (+0.98%)

FWRD Forward Air
$58.50 /

+2.09 (+3.71%)

D Dominion
$78.70 /

+1.56 (+2.02%)

D Dominion
$78.70 /

+1.56 (+2.02%)

09/29/20 JPMorgan
JPMorgan upgrades Dominion to Overweight on green growth potential
09/29/20 JPMorgan
Dominion upgraded to Overweight from Neutral at JPMorgan
08/24/20 Guggenheim
Guggenheim cuts Eversource to Neutral, prefers Dominion as offshore wind play
08/17/20 Argus
Dominion downgraded to Hold from Buy at Argus
HSY Hershey
$141.71 /

+1.37 (+0.98%)

09/29/20 BMO Capital
Hershey upgraded to Outperform from Market Perform at BMO Capital
07/24/20 Evercore ISI
Hershey upgraded to Outperform from In Line at Evercore ISI
04/24/20
Fly Intel: Top five analyst downgrades
04/24/20 BMO Capital
Hershey price target lowered to $140 from $150 at BMO Capital
SQ Square
$165.06 /

+4.3 (+2.67%)

09/29/20 Wolfe Research
Square upgraded to Outperform from Peer Perform at Wolfe Research
09/28/20 Credit Suisse
Square price target raised to $175 from $170 at Credit Suisse
09/24/20
Fly Intel: Top five analyst upgrades
09/24/20 Oppenheimer
Square upgraded to Outperform upon re-assumption of coverage at Oppenheimer
RH RH
$372.50 /

+11.84 (+3.28%)

09/29/20 Cowen
Cowen upgrades RH to Outperform with transformation in 'earlier innings'
09/29/20 Cowen
RH upgraded to Outperform from Market Perform at Cowen
09/10/20 JPMorgan
RH price target raised to $440 from $370 at JPMorgan
09/10/20 Loop Capital
RH price target raised to $400 from $300 at Loop Capital
FWRD Forward Air
$58.50 /

+2.09 (+3.71%)

09/29/20 Raymond James
Forward Air upgraded to Outperform from Market Perform at Raymond James
09/29/20 Raymond James
Forward Air upgraded to Outperform from Market Perform at Raymond James
06/09/20 Wolfe Research
Forward Air upgraded to Peer Perform from Underperform at Wolfe Research
03/27/20 Wolfe Research
Forward Air downgraded to Underperform from Peer Perform at Wolfe Research
SQ Square
$165.06 /

+4.3 (+2.67%)

RH RH
$372.50 /

+11.84 (+3.28%)

HSY Hershey
$141.71 /

+1.37 (+0.98%)

FWRD Forward Air
$58.50 /

+2.09 (+3.71%)

D Dominion
$78.70 /

+1.56 (+2.02%)

SQ Square
$165.06 /

+4.3 (+2.67%)

RH RH
$372.50 /

+11.84 (+3.28%)

HSY Hershey
$141.71 /

+1.37 (+0.98%)

D Dominion
$78.70 /

+1.56 (+2.02%)

SQ Square
$165.06 /

+4.3 (+2.67%)

RH RH
$372.50 /

+11.84 (+3.28%)

HSY Hershey
$141.71 /

+1.37 (+0.98%)

D Dominion
$78.70 /

+1.56 (+2.02%)

SQ Square
$165.06 /

+4.3 (+2.67%)

RH RH
$372.50 /

+11.84 (+3.28%)

D Dominion
$78.70 /

+1.56 (+2.02%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.